These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients. Singh K; Goyal P; Singh M; Deshmukh S; Upadhyay D; Kant S; Agrawal NK; Gupta SK; Singh K J Diabetes Complications; 2017 Dec; 31(12):1648-1651. PubMed ID: 28964682 [TBL] [Abstract][Full Text] [Related]
43. Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction. El-Aziz TAA; Mohamed RH Int J Cardiol; 2017 Jan; 227():524-528. PubMed ID: 27825726 [TBL] [Abstract][Full Text] [Related]
44. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians. Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195 [TBL] [Abstract][Full Text] [Related]
45. Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers. Luizon MR; de Almeida Belo V Biomarkers; 2012 May; 17(3):286-8. PubMed ID: 22309315 [TBL] [Abstract][Full Text] [Related]
46. Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk. Kuo CC; Tsai CW; Chang WS; Shen TC; Tzeng HE; Li CH; Wang YC; Tsai FJ; Bau DT Anticancer Res; 2020 Oct; 40(10):5751-5756. PubMed ID: 32988902 [TBL] [Abstract][Full Text] [Related]
47. MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population. Zagouri F; Sergentanis TN; Gazouli M; Dimitrakakis C; Tsigginou A; Papaspyrou I; Chrysikos D; Lymperi M; Zografos GC; Antsaklis A; Dimopoulos MA; Papadimitriou CA Mol Biol Rep; 2013 Aug; 40(8):5035-40. PubMed ID: 23661021 [TBL] [Abstract][Full Text] [Related]
48. [Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease]. Wu P; Shu Y; Li M; Luo H; Zhang G; Tan S Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1415-8. PubMed ID: 26850403 [TBL] [Abstract][Full Text] [Related]
49. Matrix metalloproteinase-9 (MMP-9) promoter -1562C/T functional polymorphism is associated with an increased risk to develop micropapillary thyroid carcinoma. Dobrescu R; Schipor S; Manda D; Caragheorgheopol A; Badiu C Cancer Biomark; 2022; 34(4):555-562. PubMed ID: 35275517 [TBL] [Abstract][Full Text] [Related]
50. Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke. Hao Y; Tian S; Sun M; Zhu Y; Nie Z; Yang S Int J Clin Exp Pathol; 2015; 8(9):11647-52. PubMed ID: 26617904 [TBL] [Abstract][Full Text] [Related]
51. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
52. Association of MMP-2, MMP-3, and MMP-9 Polymorphisms with Susceptibility to Recurrent Pregnancy Loss. Behforouz A; Dastgheib SA; Abbasi H; Karimi-Zarchi M; Javaheri A; Hadadan A; Tabatabaei RS; Meibodi B; Neamatzadeh H Fetal Pediatr Pathol; 2021 Oct; 40(5):378-386. PubMed ID: 31955640 [TBL] [Abstract][Full Text] [Related]
53. Association between the -1306C/T polymorphism of matrix metalloproteinase-2 gene and lumbar disc disease in Chinese young adults. Dong DM; Yao M; Liu B; Sun CY; Jiang YQ; Wang YS Eur Spine J; 2007 Nov; 16(11):1958-61. PubMed ID: 17680282 [TBL] [Abstract][Full Text] [Related]
54. Association of Hsu PC; Pei JS; Chen CC; Chang WS; Kuo CC; Cheng SP; Tsai CW; Bau DT; Gong CL Anticancer Res; 2019 Mar; 39(3):1185-1190. PubMed ID: 30842148 [TBL] [Abstract][Full Text] [Related]
55. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis. Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181 [TBL] [Abstract][Full Text] [Related]
56. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Kang S; Zhao X; Xing H; Wang N; Zhou R; Chen S; Li W; Zhao J; Duan Y; Sun D; Li Y Environ Mol Mutagen; 2008 Apr; 49(3):226-31. PubMed ID: 18288718 [TBL] [Abstract][Full Text] [Related]
57. Genetic polymorphisms in MMP 2, 3 and 9 genes and the susceptibility of osteosarcoma in a Chinese Han population. Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY Biomarkers; 2016; 21(2):160-3. PubMed ID: 26754027 [TBL] [Abstract][Full Text] [Related]
58. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection. Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467 [TBL] [Abstract][Full Text] [Related]